Navigation Links
Women, Younger Men Under-Treated Before Heart Attack: Study
Date:11/16/2011

WEDNESDAY, Nov. 16 (HealthDay News) -- Women and younger men account for a large number of heart attacks in the United States but are less likely than older men to receive preventive medications that lower heart attack risk, a new study indicates.

Researchers evaluated more than 3,000 heart attack patients treated at the Minneapolis Heart Institute between March 2003 and January 2010, and found that 70.3 percent of them had not been diagnosed with coronary heart disease (CHD) and 60 percent of those undiagnosed patients were men 55 and younger and women 65 and younger with premature CHD.

Even though rates of high cholesterol among the women and younger men were similar to the rate in older men, those two groups of patients were nearly half as likely (10 percent vs. 19 percent) to be taking cholesterol-lowering statins prior to their heart attack and were much less likely to be on aspirin and combination therapy.

The study was scheduled for presentation Wednesday at an American Heart Association annual meeting in Orlando, Fla.

"For those patients with known coronary disease, the evidence and guidelines are fairly clear about the benefit of aggressive medical therapy, including an aspirin and statin, regardless of your age or gender," said Dr. Michael Miedema, a cardiology fellow at the University of Minnesota working with researchers at the Minneapolis Heart Institute at Abbott Northwestern Hospital.

"However, for patients without known coronary disease, the optimal approach is much less clear," he added in an institute news release. "We currently only treat high-risk patients, but our data show that women and young males, who rarely qualify as high-risk, make up a substantial portion of the current heart attack population."

The most widely used cardiac event risk calculator is the Framingham Risk Score, which uses the patient's age, gender and factors such as cholesterol and blood pressure. But this approach is heavily weighted toward age and gender, according to Miedema.

"If you're an older male, you're much more likely to qualify for preventive therapy while females and younger males often do not meet criteria despite similar risk factors," he said.

"While older males are still the most likely group to have heart attacks, we have shown that women and patients with premature disease make up a substantial portion of the heart attacks we are seeing and very few of these patients are on the medications which research has shown to prevent heart attacks. Better methods of risk assessment could potentially allow us to target more people truly at high risk for an event and avoid excessive treatment of those who are low risk," Miedema concluded.

Research presented at meetings should be considered preliminary until published in a peer-reviewed medical journal.

More information

The U.S. National Heart, Lung, and Blood Institute has more about heart attack prevention.

-- Robert Preidt

SOURCE: Minneapolis Heart Institute, news release, Nov. 16, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Women, Diabetics Fall Fast Into Medicare Doughnut Hole
2. ICRW Says to Stop Violence against Women, Aim National Policies at Men
3. For Younger Women, Mammograms Not Too Effective: Study
4. Women, minorities more likely to see doctor of choice in emergency room
5. For some women, preventive mastectomies pay off
6. Studies Tout Alternative HIV Regimens for Women, Babies
7. Buprenorphine is better than methadone for opioid dependence in pregnant women, study shows
8. In Women, Diabetes Plus Depression a Deadly Combo
9. Men with macho faces attractive to fertile women, researchers find
10. Recalled ICD leads fail in women, youths most often
11. Surviving Melanoma May Take Different Toll on Women, Men
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Women, Younger Men Under-Treated Before Heart Attack: Study
(Date:4/21/2017)... ... ... The Patient Advocacy Community of The Beryl Institute presented Eve DeVaro, Director, Patient ... Award in recognition of her extraordinary contributions to the field of patient advocacy ... Institute’s annual Patient Experience Conference on March 20 in Denver, Colorado. ...
(Date:4/21/2017)... Hong Kong (PRWEB) , ... April 21, 2017 , ... ... Printing (U3DP), the first 3D printing facility among higher education institutions in Hong Kong ... 3D printing, in terms of the range and quantity of facilities in Hong Kong. ...
(Date:4/21/2017)... ... April 21, 2017 , ... ... AWARE: A Week of Addiction and Recovery Education, from April 24 to April ... preventing substance use disorders. , The mission of AWARE is to instill ...
(Date:4/21/2017)... , ... April 21, 2017 , ... ... announced an exciting new partnership with the highly regarded and well renowned Asian ... highly innovative, myTAP & myTAP PAP Nasal Pillow Mask, and will stabilize and ...
(Date:4/21/2017)... Worcestershire, UK (PRWEB) , ... April 21, 2017 ... ... Award for Enterprise in the category of International Trade, the UK’s most prestigious ... in international trade, which represents 95% of total revenues and has grown by ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017 Research and ... Biosimilar Pipeline and Market Prospects: Addressing Production Complexities Through ... their offering. ... "Global Biosimilar Pipeline and Market Prospects: Overcoming Production ... an in-depth assessment of the current trends in the ...
(Date:4/20/2017)... , April 20, 2017   ZappRx, Inc ., ... specialty drug prescribing process, today announced it closed $25 million ... a venture capital firm based in Seattle ... Qiming Venture Partners . The Series B round included participation ... round in 2014, and GV (formerly Google Ventures). ...
(Date:4/20/2017)... NeuroVive Pharmaceutical AB (Nasdaq Stockholm: ... preclinical results demonstrating anti-fibrotic effects with NV556, ... (NASH), in an additional well-validated experimental NASH ... previously shown similar anti-fibrotic effects in the ... present novel data demonstrating anti-fibrotic effects of ...
Breaking Medicine Technology: